Voyager Therapeutics, Inc. - VYGR
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$133.3M
QoQ value delta ($000)
-$7.129M
(-5.08%)
Implied price effect (QoQ)
-15.85%
Shares
Total shares
33,917,659
QoQ shares delta
+3,847,836
(+12.8%)
Total shares held by funds (by quarter)
Market chart (VYGR)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| BlackRock, Inc. | 22,080 | 5,618,365 | 0.0% |
| EcoR1 Capital, LLC | 15,731 | 4,002,847 | 0.71% |
| ARMISTICE CAPITAL, LLC | 15,720 | 4,000,000 | 0.19% |
| VANGUARD GROUP INC | 12,837 | 3,266,484 | 0.0% |
| MILLENNIUM MANAGEMENT LLC | 7,567 | 1,925,560 | 0.0% |
| Vestal Point Capital, LP | 5,796 | 1,475,000 | 0.2% |
| Erste Asset Management GmbH | 4,717 | 1,195,141 | 0.04% |
| Opaleye Management Inc. | 4,703 | 1,196,904 | 0.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 4,462 | 1,135,188 | 0.0% |
| DIMENSIONAL FUND ADVISORS LP | 4,262 | 1,084,499 | 0.0% |
| STATE STREET CORP | 3,679 | 936,266 | 0.0% |
| CITADEL ADVISORS LLC | 2,290 | 582,846 | 0.0% |
| MORGAN STANLEY | 2,138 | 544,114 | 0.0% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,052 | 521,651 | 0.0% |
| NORTHERN TRUST CORP | 1,448 | 368,546 | 0.0% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,335 | 339,761 | 0.26% |
| FIDUCIARY TRUST CO | 1,314 | 334,397 | 0.01% |
| JPMORGAN CHASE & CO | 1,282 | 326,230 | 0.0% |
| GOLDMAN SACHS GROUP INC | 1,191 | 303,133 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 1,165 | 296,450 | 0.0% |
| UBS Group AG | 1,056 | 268,793 | 0.0% |
| TWO SIGMA INVESTMENTS, LP | 875 | 222,713 | 0.0% |
| Altshuler Shaham Ltd | 800 | 203,740 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 692 | 176,097 | 0.0% |
| BARCLAYS PLC | 637 | 162,112 | 0.0% |